Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$ -- Ignore unavailable to you. Want to Upgrade?

To: C Wright who wrote (6579)	3/4/1998 9:50:00 PM
From: Gapman	Respond to of 9262

Ray, It's been a while but it's time to buy TRGA again. They will be presenting in Michael Murphey's biotech conference next week and I expect some great news to come out. Read the following portion of their PR release on 2/12/98. In addition, there was a huge block buyer today between the spread after which the ask moved up to 3 9/16 from 3 1/2. This baby is going higher....buy now and sell on the news next week. SAN DIEGO, Feb. 12 /PRNewswire/ -- Trega Biosciences, Inc. (Nasdaq: TRGA - news) today announced that based on screening of Trega's combinatorial chemistry libraries, Warner-Lambert has identified a series of lead compounds which are active in a Warner-Lambert biological target. In acknowledgment of Trega having met an important milestone in their May 1997 agreement, Warner-Lambert will purchase $1.5 million in Trega common stock, the timing and pricing of which will be determined by Trega over the next two years. Over the next 60 days, the companies will negotiate the terms of a broader research collaboration involving the further development of these lead compounds.